Widen­ing GLP-1 cov­er­age could cost Medicare al­most $150B an­nu­al­ly, study finds

As Con­gress con­sid­ers widen­ing Medicare’s cov­er­age of the bur­geon­ing class of weight loss med­ica­tions, a new study says fur­ther ex­pan­sion of el­i­gi­ble pa­tients in­to new …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER